- About the DEUEL Conference
- DEUEL Board
- The Havel Lecture
- Program
- Registration
- PostDocs & Trainees
- Speaker Information
- Hotel
- Sponsors
Program
Conference Program in PDF Format
|
2010 DEUEL Program Chair Peter Tontonoz |
|
2010 DEUEL Program Co-Chair Kathryn J. Moore |
2010 Deuel Conference on Lipids, March 3-5, 2010
Laguna Cliffs Marriott Resort, Dana Point, CA
Preliminary Conference Program
Tuesday, March 2, 4:00 PM to 9:00 PM
Registration, Reception, and Dinner
Wednesday, March 3, 8:45 AM to 12:30 PM
Session Leader: Kathryn J. Moore
Session 1 Macrophage Signaling in Lipid Metabolism and Disease
8:30-9:05 “The path to macrophage foam cell formation”
Kathryn J. Moore, New York University, New York
9:05-9:40 “Tissue macrophages in inflammation-induced insulin resistance and dyslipidemia”
Jerrold Olefsky, University of California, San Diego
9:40-10:00 “Atherosclerosis and apoptosis in Abcg1-/-ApoE-/- mice”
Elizabeth Tarling, University of California, Los Angeles
10:00-10:20 Coffee Break
10:20-10:55 “Mechanisms of Atherosclerotic Lesion Regression”
Edward Fisher, New York University, New York
10:55-11:30 “Fatty acids and Acyl-CoAs, Macrophages, and Atherosclerosis”
Karin E. Bornfeldt, University of Washington, Seattle
11:30-11:50 “Characterization of oxidized lipids in cholesterol-fed zebrafish”
Yuri Miller, University of California, San Diego
Wednesday, March 3, 7:30 to 9:30 PM
Session Leader: Peter Tontonoz
The Havel Lecture
“Nuclear receptor control of lipid metabolism”
David J. Mangelsdorf, University of Texas Southwestern Medical Center, Dallas
Wine reception and Trainees’ Poster Session
Poster Board dimension: 4’ high x 6’ wide, with useable board space measuring: 44.5” h x 69" w.
Thursday, March 4, 8:45 AM to 12:30 PM
Session Leader: Jay Horton
Session 2 Mechanisms of Metabolic Control
8:30-9:05 “Fat regulation in C. elegans”
Kaveh Ashrafi, University of California, San Francisco
9:05-9:40 “Lipins: Multifunctional lipid phosphatases”
Karen Reue, University of California, Los Angeles
9:40-10:00 “Cavin-2 is a cell surface cholesterol sensor linking caveolae to the cytoskeleton”
Michael Breen, Boston University, Boston
10:00-10:20 Coffee Break
10:20-10:55 "Oxysterol regulation of cholesterol homeostasis”
Daniel Ory, Washington University, St. Louis
10:55-11:30 "New insights into mechanisms for ER-associated degradation of HMG CoA reductase”
Russell Debose-Boyd, University of Texas Southwestern Medical Center, Dallas
Erin Foley, University of California, San Diego
Thursday, March 4, 7:30 to 9:30 PM
Session Leader: Joseph Witztum
Session 3 Systemic Approaches to Metabolic Disease
7:30-8:05 “Metabolic mechanisms of tissue failure in type 2 diabetes”
Christopher Newgard, Duke University
8:05-8:40 “Hypothalamic regulation of energy balance”
Randy Seeley, University of Cincinnati
8:40-9:15 “Endothelial Control of Metabolism”
Jorge Plutzky, Brigham and Women’s Hospital, Boston
9:15-9:35 “FGF15/19 and FGF21 govern fed and fasted responses in the liver”
Matthew Potthoff, University of Texas Southwestern, Dallas
Friday, March 5, 8:30 AM to 12:00 noon
Session Leader: Steven G. Young
Session 4 Human Metabolism and Therapeutic Opportunities
8:30-9:05 The JLR Lecture: “Functional analysis of new genes regulating plasma lipoproteins”
Daniel J. Rader, University of Pennsylvania, Philadelphia
9:05-9:40 “New Connections Between Insulin Resistance, Diabetes and Cholesterol Metabolism”
C. Ronald Kahn, Joslin Diabetes Center, Harvard Medical School
9:40-10:00 Coffee Break
10:00-10:35 "Inflammation, adipocytes and modulation of HDL”
Muredach Reilly, University of Pennsylvania, Philadelphia
10:35-11:10 “Antisense Inhibition of ApoB:From Bench to Clinic”
Rosanne M. Crooke, Isis Pharmaceuticals, Carlsbad
11:10-11:45 “Therapeutic potential of FGF-21”
Murielle Veniant-Ellison, Amgen, Thousand Oaks